The Perceptual Standards Board
The Perceptual Standards Board
Overview
The Perceptual Standards Board is the regulatory body that oversees neural advertising in the Sprawl. It is funded by the advertising industry it regulates. It has rejected one advertising technique in fifteen years.
That technique — Guardian's amygdala stimulation protocol, 2178 — caused sustained insomnia in 34% of exposed subjects. The insomnia reduced quarterly productivity outputs by an estimated 11.2% across affected sectors. The Board's rejection filing runs nine pages. The word "insomnia" appears fourteen times. The word "manipulation" appears zero times.
The Board was established in 2171 by Nexus Dynamics as a preemptive measure to forestall regulation of neural advertising under Zephyria's emerging Consciousness Rights framework. The logic was efficient: an industry that regulates itself cannot be regulated by others. The seven members include three advertising industry representatives, two Nexus executives, one Helix neuroscientist, and one "public interest advocate" selected from a short list maintained by Good Fortune's public affairs division.
The Board reviews proposed techniques for "perceptual safety" — ensuring advertising does not produce adverse neurological effects, does not impair cognitive function, and does not exceed "reasonable" influence thresholds. It has approved 847 techniques. Its definitions of "adverse," "impair," and "reasonable" have been revised forty-one times since 2171, always in the direction of greater permissiveness, always unanimously.
The Productivity Standard
The Board does not regulate manipulation. The Board regulates whether manipulation makes workers miss shifts.
This is not subtext. It is the recorded operational logic of every filing the Board has produced since 2171. The seven members do not ask "does this technique influence the user?" All neural advertising influences by design. They ask "does this influence reduce the user's value as an economic unit?" The answer determines everything.
In 2179, the Board approved CLP-mediated craving induction for Wholesome branded nutrition — a technique that generates measurable hunger responses in subjects who have already eaten. The technique causes documented caloric overconsumption in 67% of exposed users. Approval was unanimous. The filing notes that "appetite stimulation within non-pathological ranges does not constitute cognitive impairment." The users eat more. Wholesome sells more. Nobody misses work.
The same year, the Board reviewed a technique for ambient anxiety elevation designed to increase urgency in Good Fortune loan applications. The technique worked. Approval rate among exposed populations rose 23%. It also produced a 4% spike in absenteeism — subjects reported feeling "generally unwell" on mornings following exposure. The technique was sent back for revision. Not rejected. Revised. The resubmitted version achieved the same anxiety response with a 0.7% absenteeism rate. Approved unanimously. The loan application spike held at 19%.
The pattern is consistent across all 847 approvals. Craving induction, aspiration modeling, social comparison amplification, purchase urgency, brand loyalty reinforcement — each technique reshapes cognition toward a commercial outcome. Each was approved provided the reshaping did not impair the subject's capacity to show up for work the next morning. A technique that makes you want things you don't need is perceptually safe. A technique that makes you too anxious to leave your apartment is a productivity risk. The Three megacorporations that fund the Board's operations have never disagreed on this distinction.
Guardian's amygdala stimulation remains the sole rejection because Guardian failed to solve the productivity problem before resubmitting. The manipulation was fine. The sick days were not.
The Approval Pipeline
The 99.9% approval rate is not corruption. It is selection bias.
Nexus maintains a pre-submission consultation service — technically independent from the Board, housed in the same building, staffed by two former Board members — where advertising firms can test their techniques against likely Board criteria before formal review. Techniques that would fail are identified early and either modified or shelved. The consultation service charges 12,000 credits per review. It has processed approximately 3,200 techniques since 2175. Roughly 2,350 were withdrawn or modified before reaching the Board.
The techniques that reach the seven members on the 52nd floor of Nexus Central have already been pre-filtered for approval. The quarterly meetings last, on average, forty-seven minutes. The proceedings are recorded on infrastructure maintained by Nexus's data division — the same servers that process the CLP-mediated advertising the Board is reviewing. The recordings are classified. No one has requested access.
Jurisdictional Architecture
The Board regulates neural advertising. It does not regulate the Attention Tithe. It does not regulate the Calibration. It does not regulate the Smoothing. It does not regulate any form of value injection not explicitly classified as "advertising."
The distinction between "advertising" (regulated, Board-approved, legally shielded) and "value injection" (unregulated, uncategorized, functionally identical) is maintained by the same corporations that profit from maintaining it. The Value Injection ecosystem operates in the space the Board was designed to leave empty. The Attention Abolitionists have filed seven formal challenges to the Board's jurisdictional boundaries since 2177. Each challenge was reviewed by the Board itself. Each was denied.
In Zephyria, the Board has no jurisdiction, and the Consciousness Rights Act applies standards the Board would not survive. In the Deep Dregs, the Board is unknown — residents who bear the densest neural advertising exposure in the Sprawl have never heard of the body that approved the techniques reshaping their cognition.
Sensory Details
The Board meets quarterly in a conference room on the 52nd floor of Nexus Central's regulatory wing. Temperature-controlled at 22°C — the standard Nexus comfort setting, identical to the ambient temperature in Nexus's sensory advertising development suites. The lighting is calibrated for cognitive clarity at 5,200 Kelvin. The seven members sit at a curved table facing a holographic display of the technique under review. The Helix neuroscientist sits at the far left of the curve, where the display resolution drops 12% due to viewing angle. She has requested a seat change twice. The requests were tabled.
Visual Identity
- Color palette: Corporate blue (#0066CC) with regulatory gold (#FFD700) trim
- Key symbol: A rubber stamp — the Board's most honest visual
- Lighting: Institutional blue-white at 5,200K — the cold clarity of a process designed to produce approval, not discomfort
Connected To
Featured in weaves
Long-form threads that walk through this entity.